PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1577010
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1577010
Airway Clearance Devices Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
The Global Airway Clearance Devices Market was valued at USD 646.2 million in 2023 and will exceed USD 1 billion by 2032, with a 5.1% CAGR from 2024 to 2032. The increasing prevalence of respiratory diseases, such as COPD and asthma, is significantly driving the growth of the industry, as these conditions create a heightened demand for effective management solutions. Also, improving healthcare infrastructure is contributing to market expansion by enhancing access to advanced medical devices and treatment options. The combination of a growing patient population requiring respiratory support and the development of better healthcare facilities will boost the market size for airway clearance devices significantly.
The airway clearance devices market is divided based on device type, application, end use , and region.
The oscillatory positive expiratory pressure (OPEP) segment will secure 5.5% CAGR through 2032 due to its effectiveness in managing chronic respiratory conditions. OPEP devices utilize oscillatory pressure to help clear mucus from the airways, improving lung function and patient outcomes. Their proven benefits, ease of use, and increasing adoption in both clinical and home settings contribute to their dominance. As awareness and demand for effective respiratory therapies rise, the OPEP segment will lead the market.
The chronic obstructive pulmonary disease (COPD) segment will expand to USD 422.3 million in 2032, owing to the high prevalence and severity of this condition. COPD patients often require specialized devices to manage their symptoms and improve their quality of life. The increasing incidence of COPD, combined with advancements in airway clearance technologies, drives demand for effective management solutions. As awareness of COPD grows and treatment options expand, this segment will dominate the market, reflecting its critical role in respiratory care.
North America airway clearance devices industry generated revenue of USD 255.6 million in 2023, fueled by its advanced healthcare infrastructure and high prevalence of respiratory diseases. The region benefits from significant investments in medical technology and a well-established healthcare system that supports the adoption of innovative airway clearance solutions. Additionally, increasing awareness and healthcare initiatives aimed at managing chronic respiratory conditions further boost market growth. North America's robust healthcare environment makes it a key contributor to the airway clearance devices market.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market scope and definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rise in incidence of respiratory conditions
- 3.2.1.2 Growing patient awareness and product launches
- 3.2.1.3 Increasing adoption of non-invasive treatment options
- 3.2.1.4 Surge in government initiatives towards controlling respiratory disorders
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 High device cost and stringent regulatory requirements
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Reimbursement scenario
- 3.6 Technological landscape
- 3.7 Application potential
- 3.8 Initiatives/policy landscape
- 3.9 Gap analysis
- 3.10 Future market trends
- 3.11 Porter's analysis
- 3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Company market share analysis
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Device Type, 2021 - 2032 ($ Mn and Units)
- 5.1 Key trends
- 5.2 Oscillatory positive expiratory pressure (OPEP)
- 5.3 High frequency chest wall oscillation (HFCWO)
- 5.4 Intrapulmonary percussive ventilation (IPV)
- 5.5 Other device types
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Chronic obstructive pulmonary disease (COPD)
- 6.3 Bronchiectasis
- 6.4 Cystic fibrosis
- 6.5 Neuromuscular
- 6.6 Other applications
Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Home care settings
- 7.3 Hospitals
- 7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 ABM Respiratory Care
- 9.2 Dymedso Inc.
- 9.3 Electromed Inc.
- 9.4 Hill-Rom Holdings, Inc./Baxter International
- 9.5 ICU Medical
- 9.6 Koninklijke Philips N.V.
- 9.7 Mercury Medical
- 9.8 Monaghan Medical Corporation
- 9.9 Pari Medical Holding GmbH
- 9.10 Pneumo Care Health Private Limited.
- 9.11 Tactile Medical
- 9.12 Thayer Medical
- 9.13 VORTRAN Medical Technology 1 Inc.
- 9.14 Vyaire Medical, Inc.
